22
Nov
Medical research: Prior consultation with the Data Protection Authority is no longer required
Medical research is one of the areas most affected by rapid technological development and increased use of artificial intelligence (AI) systems.
21
Nov
The Dabus case: Artificial intelligence cannot be designated as the inventor in a patent
Artificial intelligence plays a fundamental role in the life sciences sector, offering the opportunity to facilitate various processes. However, such use also raises numerous ethical and legal questions that touch on responsibility, reliability, and the correct and legal use of data and information to train AI for new technical solutions.
21
Nov
Transparency in clinical trials: Revised transparency rules take effect
The major changes under the revised transparency rules for the Clinical Trials Regulation and its Clinical Trials Information System, issued by the EMA in October 2023, should lead to faster publication of key documents (including protocols) and should make the system easier to use.
30
May
Patient access to new digital therapies: challenges and opportunities of digital therapeutics in the EU
This article has been first published on April 30, 2024 on the International Bar Association (IBA)'s newsletter.
23
Apr
Italian Data Protection Authority publishes rules for platforms (websites or apps) connecting patients and healthcare professionals
The evolution of online platforms and apps that connect patients with healthcare professionals has made medical care more accessible, but it has also raised important issues concerning privacy and the protection of personal data.
18
Apr
Chatbots and virtual assistants: How might they be used in pharmaceuticals?
The pharmaceutical sector is not immune to the paradigm shift in user/patient relations, connected to the development and implementation of artificial intelligence systems: when browsing the web and using smartphone applications, users increasingly encounter chatbots and virtual assistants that interact with them.
